Skip to main content
Fig. 5 | BMC Ophthalmology

Fig. 5

From: The efficacy and safety of micropulse transscleral laser treatment in glaucoma: a systematic review and meta-analysis

Fig. 5

Meta-analysis of mTLT compared to CW-TSCPC in NOAM reduction at various follow-up visits. A total of 103 patients treated with mTLT and 215 patients treated with CW-TSCPC were included. The NOAM reduction was lower at 1 month (WMD=-0.30, 95% CI -0.54 to -0.06), and 3 months (WMD=-0.39, 95% CI -0.63 to -0.15) in mTLT, while there was no significant change at 1–2 weeks, and 6 months

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us